Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes

BACKGROUND: Both Alzheimer’s disease (AD) and type 2 diabetes (T2D) share common pathological features including inflammation, insulin signaling alterations, or vascular damage. AD has no successful treatment, and the close relationship between both diseases supports the study of antidiabetic drugs...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Alzheimers Res Ther
Asıl Yazarlar: Hierro-Bujalance, Carmen, Infante-Garcia, Carmen, del Marco, Angel, Herrera, Marta, Carranza-Naval, Maria Jose, Suarez, Javier, Alves-Martinez, Pilar, Lubian-Lopez, Simon, Garcia-Alloza, Monica
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2020
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7140573/
https://ncbi.nlm.nih.gov/pubmed/32264944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-020-00607-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller